Antithrombin supplementation during extracorporeal membrane oxygenation: study protocol for a pilot randomized clinical trial

BACKGROUND: Normal levels of plasma antithrombin (AT) activity might decrease heparin requirements to achieve an adequate level of anticoagulation during treatment with extracorporeal membrane oxygenation (ECMO). Acquired AT deficiency during ECMO is common, but formal recommendations on target, tim...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Trials
Hauptverfasser: Panigada, Mauro, Spinelli, Elena, Cucino, Alberto, Cipriani, Elisa, De Falco, Stefano, Panarello, Giovanna, Occhipinti, Giovanna, Arcadipane, Antonio, Sales, Gabriele, Fanelli, Vito, Brazzi, Luca, Novembrino, Cristina, Consonni, Dario, Pesenti, Antonio, Grasselli, Giacomo
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Study Protocol
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6558738/
https://ncbi.nlm.nih.gov/pubmed/31186035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-019-3386-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge